Nexus Clinical Research (India) Limited - Company Profile

It is a pharma public limited company based in Navi Mumbai, Maharashtra, India, established in 2005.

2005 Navi Mumbai, Maharashtra, India Active

Last Updated: February 17, 2026

About Nexus Clinical Research (India) Limited

Nexus Clinical Research (India) Limited, a active public limited company, was established on 22 November 2005 in Navi Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U99999MH2005PLC157715. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Formerly known as Nexus Clinical Research Private Limited, Nexus Clinical Research (India) Private Limited. It upholds a compliant status. Its leadership includes Meghna Amit Bhatt (Director), Amit Bhatt (Director), Amol Jagahnathrao Ghate (Director). Past directors included Amit Bhatt, Amol Jagahnathrao Ghate, Tej Nath Bhat. It holds ₹3.16 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Anuj Plot No. 45, 1St Floor, Mumbai-Pune Highway Sector-13, Nerul(E), Navi Mumbai, Maharashtra, 400706.

Company Details

CIN/LLPIN
U99999MH2005PLC157715
Registration Number
157715
Incorporation Date
22 November 2005
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Mumbai Ii
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 17-02-2026
Paid Up Capital ₹ 0.50 M as on 17-02-2026
Company Age 20 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 3.16 Cr as on 17-02-2026
Revenue Growth **** % (FY 2023)
Profit Growth **** 37.47% (FY 2023)
Ebitda **** 88.28% (FY 2023)
Net Worth -14.70% (FY 2023)
Total Assets -12.78% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Nexus Clinical Research (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nexus Clinical Research (India) Limited?

Current Directors

Name	Designation	Appointment Date	Status
Meghna Amit Bhatt	Director	01 Dec 2005	Current
Amit Bhatt	Director	15 Dec 2018	Current
Amol Jagahnathrao Ghate	Director	04 Jul 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	03 Jul 2017	Past
Pramod Abcsdd	Additional Director	28 Sep 2017	Past
Pramod Abcsdd	Director	15 Dec 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nexus Clinical Research (India).

Nexus Clinical Research (India) Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.47% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.7%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

-12.78%

*******

Profit or Loss

*******

37.47%

*******

Net Worth

*******

-14.70%

*******

EBITDA

*******

88.28%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nexus Clinical Research (India)?

In 2023, Nexus Clinical Research (India) had a promoter holding of 99.79% and a public holding of 0.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹31,601,246.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 2.11 Cr
Dewan Housing Finance Corporation Limited : 1.05 Cr

Latest Charge Details

Date	Lender	Amount	Status
11 Sep 2018	Others	₹2.11 Cr	Open
27 May 2015	Dewan Housing Finance Corporation Limited	₹1.05 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Nexus Clinical Research (India)?

Unlock and access historical data on people associated with Nexus Clinical Research (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nexus Clinical Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Clinical Research (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nexus Clinical Research (India)

Recent Activity within the Organization

Annual General Meeting

The activity Nexus Clinical Research (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Nexus Clinical Research (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity Amit Bhatt was appointed as a Director was appointed as a Director on 15 Dec 2018 & has been associated with this company since 7 years 2 months . was completed.
15 Dec 2018
Charges

The activity A charge with Others amounted to Rs. 21.05 M with Charge ID 100203864 was registered on 11 Sep 2018. was completed.
11 Sep 2018
Director Appointment

Amol Jagahnathrao Ghate was appointed as a Director was appointed as a Director on 04 Jul 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
04 Jul 2017
Charges

The activity A charge with Dewan Housing Finance Corporation Limited amounted to Rs. 10.55 M with Charge ID 10582815 was registered on 27 May 2015. was completed.
27 May 2015

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Nexus Clinical Research (India) Limited?

The CIN of Nexus Clinical Research (India) Limited is U99999MH2005PLC157715.

Where is Nexus Clinical Research (India) Limited headquartered?

Nexus Clinical Research (India) Limited is headquartered at Anuj Plot No. 45, 1St Floor, Mumbai-Pune Highway Sector-13, Nerul(E), Navi Mumbai, Maharashtra, 400706.

When was Nexus Clinical Research (India) Limited incorporated?

Nexus Clinical Research (India) Limited was incorporated on 22 November 2005.

Who are the current directors of Nexus Clinical Research (India) Limited?

The current directors of Nexus Clinical Research (India) Limited are

What is the primary industry of Nexus Clinical Research (India) Limited?

The primary industry of Nexus Clinical Research (India) Limited is Professional, Scientific And Technical.

Is Nexus Clinical Research (India) Limited a listed company?

Nexus Clinical Research (India) Limited is unlisted.

What is the capital structure of Nexus Clinical Research (India) Limited?

The authorized capital of Nexus Clinical Research (India) Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Nexus Clinical Research (India) Limited?

The compliance status of Nexus Clinical Research (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available